Lauren S. Schlesselman, PharmD

home / authors / lauren-s-schlesselman-pharmd

Articles

Site Logo

Case Studies

Lauren S. Schlesselman, PharmD;Marina Grgas, PharmD
June 1st 2008

Read More

Site Logo

Case Studies

Lauren S. Schlesselman, PharmD;Marina Grgas, PharmD Candidate
May 1st 2008

Read More

Site Logo

Case Studies

Lauren S. Schlesselman, PharmD
April 1st 2008

Read More

Site Logo

Case Studies

Lauren S. Schlesselman, PharmD
March 1st 2008

Read More

Site Logo

Case Studies

Lauren S. Schlesselman, PharmD
February 1st 2008

Read More

Site Logo

Case Studies

Lauren S. Schlesselman, PharmD
January 1st 2008

Read More

Site Logo

Case Studies

Lauren S. Schlesselman, PharmD
December 1st 2007

Read More

Site Logo

Case Studies

Lauren S. Schlesselman, PharmD
November 1st 2007

Read More

Site Logo

case STUDIES

Lauren S. Schlesselman, PharmD
October 1st 2007

Dr. Schlesselman is an assistant clinical professor at the University of Connecticut School of Pharmacy.

Read More

Site Logo

case STUDIES

Lauren S. Schlesselman, PharmD
September 1st 2007

Dr. Schlesselman is an assistant clinical professor at the University of Connecticut School of Pharmacy.

Read More

Site Logo

caseSTUDIES

Lauren S. Schlesselman, PharmD
August 1st 2007

Dr. Schlesselman is an assistant clinical professor at the University of Connecticut School of Pharmacy.

Read More

Site Logo

caseSTUDIES

Lauren S. Schlesselman, PharmD
July 1st 2007

Read More

Site Logo

case STUDIES

Lauren S. Schlesselman, PharmD
June 1st 2007

Read More

Site Logo

case STUDIES

Lauren S. Schlesselman, PharmD
May 1st 2007

Read More

Site Logo

case STUDIES

Lauren S. Schlesselman, PharmD
April 1st 2007

Read More

Site Logo

case STUDIES

Lauren S. Schlesselman, PharmD
March 1st 2007

Read More

Site Logo

case STUDIES

Lauren S. Schlesselman, PharmD
February 1st 2007

Read More

Site Logo

case STUDIES

Lauren S. Schlesselman, PharmD;Christopher Konecny
January 1st 2007

Read More

Site Logo

case STUDIES

Lauren S. Schlesselman, PharmD
December 1st 2006

Read More

Site Logo

case STUDIES

Lauren S. Schlesselman, PharmD
November 1st 2006

Read More

Site Logo

case STUDY

Lauren S. Schlesselman, PharmD
October 1st 2006

Read More

Site Logo

case STUDY

Lauren S. Schlesselman, PharmD
September 1st 2006

Read More

Site Logo

case STUDIES

Lauren S. Schlesselman, PharmD
August 1st 2006

Read More

Site Logo

Case Studies

Lauren S. Schlesselman, PharmD
July 1st 2006

Read More

Site Logo

case STUDIES

Lauren S. Schlesselman, PharmD
June 1st 2006

Read More

Site Logo

caseSTUDIES

Lauren S. Schlesselman, PharmD
March 1st 2006

Read More

Site Logo

case STUDIES

Lauren S. Schlesselman, PharmD
February 1st 2006

Read More

Site Logo

case STUDIES

Lauren S. Schlesselman, PharmD
January 1st 2006

Read More

Site Logo

Case STUDIES

Lauren S. Schlesselman, PharmD
December 1st 2005

Read More

Site Logo

CASE STUDIES

Lauren S. Schlesselman, PharmD
November 1st 2005

Read More

123>

Latest Updated Articles

AI patient pharmacist provider interactions ASHP summer
Published: June 11th 2024 | Updated: July 27th 2024
Balancing Trust and Technology: The Role of AI in Patient-Pharmacist Interactions
AI pharmacy futures AI disparities skin
Published: June 11th 2024 | Updated: July 27th 2024
Addressing Disparities in AI-Driven Diagnostics: Ethical and Practical Implications
Vice President Kamala Harris -- Image credit: Erin Schaff/Pool/AFP | GETTY | People.com
Published: July 23rd 2024 | Updated: July 27th 2024
VP Kamala Harris’s Policies and Stances on Health Care, Reproductive Rights Take Center Stage
3d illustration of Abstract medical background with Diseased liver - Image credit: Rasi | stock.adobe.com
Published: October 18th 2023 | Updated: July 27th 2024
Pharmacists Can Optimize Treatment for Patients with NASH, Decreasing Economic Burden
Small vial of influenza vaccine.
Published: July 23rd 2024 | Updated: July 27th 2024
Trivalent Influenza Vaccines Are Readied for Fall
Eye Care Pharmacy | Image Credit: I Viewfinder - stock.adobe.com
Published: July 15th 2024 | Updated: July 27th 2024
Biosimilar Ranibizumab Could be More Cost-Effective Than Aflibercept for nAMD